These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23041602)

  • 1. Cancer vaccines and T cell therapy.
    Rezvani K; Brody JD; Kohrt HE; Logan AC; Advani R; Czerwinski DK; Weng WK; Negrin RS; Carlton V; Faham M; Levy R; Barrett J
    Biol Blood Marrow Transplant; 2013 Jan; 19(1 Suppl):S97-S101. PubMed ID: 23041602
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancing graft-versus-leukemia after transplant: the rise of anti-cancer vaccines.
    Brusic A; Wu CJ
    Front Biosci (Landmark Ed); 2012 Jan; 17(2):635-55. PubMed ID: 22201766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8(+) T-cell immunity against cancer-testis antigens develops following allogeneic stem cell transplantation and reveals a potential mechanism for the graft-versus-leukemia effect.
    McLarnon A; Piper KP; Goodyear OC; Arrazi JM; Mahendra P; Cook M; Clark F; Pratt G; Craddock C; Moss PA
    Haematologica; 2010 Sep; 95(9):1572-8. PubMed ID: 20460638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding and enhancing the graft-versus-leukemia effect after hematopoietic stem cell transplantation.
    Molldrem J; Riddell S
    Cancer Treat Res; 2009; 144():187-208. PubMed ID: 19779869
    [No Abstract]   [Full Text] [Related]  

  • 5. Can Graft vs. Leukemia Effect Be Uncoupled From Graft vs. Host Disease? An Examination of Proportions.
    Krieger E; Toor AA
    Front Immunol; 2020; 11():777. PubMed ID: 32425947
    [No Abstract]   [Full Text] [Related]  

  • 6. During acute graft versus host disease CD28 deletion in donor CD8
    Uri A; Lühder F; Kerkau T; Beyersdorf N
    Eur J Immunol; 2018 Dec; 48(12):2055-2067. PubMed ID: 30320878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minor histocompatibility antigens as targets of graft-versus-leukemia reactions.
    Falkenburg JH; Marijt WA; Heemskerk MH; Willemze R
    Curr Opin Hematol; 2002 Nov; 9(6):497-502. PubMed ID: 12394171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpressed differentiation antigens as targets of graft-versus-leukemia reactions.
    Molldrem JJ; Komanduri K; Wieder E
    Curr Opin Hematol; 2002 Nov; 9(6):503-8. PubMed ID: 12394172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric analysis of the graft-versus-Leukemia-effect after hematopoietic stem cell transplantation in mice.
    Schmidt F; Hilger N; Oelkrug C; Svanidze E; Ruschpler P; Eichler W; Boldt A; Emmrich F; Fricke S
    Cytometry A; 2015 Apr; 87(4):334-45. PubMed ID: 25717029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft versus leukemia reactivity after allogeneic stem cell transplantation.
    Falkenburg JH; Warren EH
    Biol Blood Marrow Transplant; 2011 Jan; 17(1 Suppl):S33-8. PubMed ID: 21195308
    [No Abstract]   [Full Text] [Related]  

  • 11. Current Status of Leukemia Cytotherapy - Exploitation with Immune Cells.
    Bao H; Wu D
    Curr Stem Cell Res Ther; 2017; 12(3):188-196. PubMed ID: 28025936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there really a specific graft-versus-leukaemia effect?
    Gale RP; Fuchs EJ
    Bone Marrow Transplant; 2016 Nov; 51(11):1413-1415. PubMed ID: 27400069
    [No Abstract]   [Full Text] [Related]  

  • 13. Invariant NKT Cells From Donor Lymphocyte Infusions (DLI-iNKTs) Promote
    Jahnke S; Schmid H; Secker KA; Einhaus J; Duerr-Stoerzer S; Keppeler H; Schober-Melms I; Baur R; Schumm M; Handgretinger R; Bethge W; Kanz L; Schneidawind C; Schneidawind D
    Front Immunol; 2019; 10():1542. PubMed ID: 31354710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective graft-versus-leukemia depends on magnitude and diversity of the alloreactive T cell response.
    van Bergen CA; van Luxemburg-Heijs SA; de Wreede LC; Eefting M; von dem Borne PA; van Balen P; Heemskerk MH; Mulder A; Claas FH; Navarrete MA; Honders WM; Rutten CE; Veelken H; Jedema I; Halkes CJ; Griffioen M; Falkenburg JH
    J Clin Invest; 2017 Feb; 127(2):517-529. PubMed ID: 28067665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor lymphocyte infusion induces polyspecific CD8(+) T-cell responses with concurrent molecular remission in acute myeloid leukemia with NPM1 mutation.
    Hofmann S; Götz M; Schneider V; Guillaume P; Bunjes D; Döhner H; Wiesneth M; Greiner J
    J Clin Oncol; 2013 Jan; 31(3):e44-7. PubMed ID: 23248243
    [No Abstract]   [Full Text] [Related]  

  • 16. Hematopoietic stem cell transplantation and cellular therapy.
    Kolb HJ
    HLA; 2017 May; 89(5):267-277. PubMed ID: 28371460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How low can the doses go? Transplanters look to less toxic future.
    Vastag B
    J Natl Cancer Inst; 2000 Aug; 92(16):1284-7. PubMed ID: 10944541
    [No Abstract]   [Full Text] [Related]  

  • 18. Graft-versus-leukemia effects of transplantation and donor lymphocytes.
    Kolb HJ
    Blood; 2008 Dec; 112(12):4371-83. PubMed ID: 19029455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma.
    Fowler DH; Gress RE
    Leuk Lymphoma; 2000 Jul; 38(3-4):221-34. PubMed ID: 10830730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination strategies to improve outcome of hematopoietic stem cell transplant in leukemia patients: early evidence and future prospects.
    Hosen N; Maeda T; Hashii Y; Tsuboi A; Nishida S; Nakata J; Nakae Y; Takashima S; Oji Y; Oka Y; Kumanogoh A; Sugiyama H
    Expert Rev Hematol; 2014 Oct; 7(5):671-81. PubMed ID: 25186852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.